FDA approved a PD-L1 companion test to identify patients with ovarian, fallopian tube or primary peritoneal cancer who may receive first-line Keytruda. The U.S. Food and Drug Administration (FDA) has ...
Researchers at the University of Georgia's Center for Tropical and Emerging Global Diseases have developed the first test to determine whether treatment for Chagas disease was effective. The study is ...
DLL3 expression on circulating tumor cells may predict Imdelltra response in small cell lung cancer patients, aiding personalized treatment decisions. High DLL3 expression correlates with positive ...
A new test for breast cancer patients has been developed which can predict whether or not their cancer is likely to return just two weeks after they start treatment. Experts said thousands of breast ...
Hepatitis C is a tiny virus with a significant impact. It's a small RNA virus that spreads through the blood and infects the liver. Even though today's medicines can cure it, hepatitis C remains a ...
Blood test-guided treatment with AstraZeneca pill cut risk of breast cancer progression, study finds
British pharmaceutical company AstraZeneca's manufacturing site in Macclesfield, northwest England. 2014 File Photo / Agence France-Presse CHICAGO — Treating breast cancer patients with AstraZeneca’s ...
Credit: Getty Images. Starting treatment for advanced NSCLC before receiving genomic test results compromises patient outcomes, a study suggests. Starting treatment for advanced non-small cell lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results